• Tue, July 7, 2020
  • Wed, July 8, 2020

Anupam Rama Initiated (TBPH) at Buy and Held Target at $29 on, Jul 7th, 2020

Anupam Rama of JP Morgan, Initiated "Theravance Biopharma, Inc." (TBPH) at Buy and Held Target at $29 on, Jul 7th, 2020.

Anupam has made no other calls on TBPH in the last 4 months.



There are 2 other peers that have a rating on TBPH. Out of the 2 peers that are also analyzing TBPH, 1 agrees with Anupam's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Vikram Purohit of "Morgan Stanley" Initiated at Hold and Held Target at $30 on, Monday, June 15th, 2020


This is the rating of the analyst that currently disagrees with Anupam


  • Marc Frahm of "Cowen & Co." Initiated at Buy and Held Target at $42 on, Wednesday, May 13th, 2020

Like: 👍